Suppr超能文献

一种鼠类尾部淋巴水肿模型。

A Murine Tail Lymphedema Model.

机构信息

Department of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine;

Department of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine.

出版信息

J Vis Exp. 2021 Feb 10(168). doi: 10.3791/61848.

Abstract

Lymphedema is extremity swelling caused by lymphatic dysfunction. The affected limb enlarges because of accumulation of fluid, adipose, and fibrosis. There is no cure for this disease. A mouse tail model that uses a focal full thickness skin excision near the base of the tail, resulting in tail swelling, has been used to study lymphedema. However, this model may result in vascular comprise and consequent tail necrosis and early tail swelling resolution, limiting its clinical translatability. The chronic murine tail lymphedema model induces sustained lymphedema over 15 weeks and a reliable perfusion to the tail. Enhancements of the traditional murine tail lymphedema model include 1) precise full thickness excision and lymphatic clipping using a surgical microscope, 2) confirmation of post-operative arterial and venous perfusion using high resolution laser speckle, and 3) functional assessment using indocyanine green near infrared laser lymphangiography. We also use tissue nanotransfection technology (TNT) for novel non-viral, transcutaneous, focal delivery of genetic cargo to the mouse tail vasculature.

摘要

淋巴水肿是由淋巴功能障碍引起的肢体肿胀。受累肢体由于液体、脂肪和纤维组织的积累而增大。目前这种疾病尚无治愈方法。一种使用尾巴底部的全层皮肤切除来造成尾巴肿胀的小鼠尾巴模型,已被用于研究淋巴水肿。然而,这种模型可能导致血管损伤和随之而来的尾巴坏死和早期尾巴肿胀消退,限制了其临床转化。慢性小鼠尾巴淋巴水肿模型可诱导 15 周以上的持续淋巴水肿和尾巴的可靠灌注。传统小鼠尾巴淋巴水肿模型的改进包括 1)使用手术显微镜进行精确的全层切除和淋巴管夹闭,2)使用高分辨率激光散斑确认术后动脉和静脉灌注,3)使用吲哚菁绿近红外激光淋巴管造影进行功能评估。我们还使用组织纳米转染技术(TNT)将新型非病毒、经皮、局灶性基因载体递送至小鼠尾巴血管。

相似文献

1
A Murine Tail Lymphedema Model.
J Vis Exp. 2021 Feb 10(168). doi: 10.3791/61848.
2
Quantification of Lymphangiogenesis in the Murine Lymphedema Tail Model Using Intravital Microscopy.
Lymphat Res Biol. 2024 Jun;22(3):195-202. doi: 10.1089/lrb.2023.0048. Epub 2024 May 3.
3
Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.
Microvasc Res. 2006 Nov;72(3):161-71. doi: 10.1016/j.mvr.2006.05.009. Epub 2006 Jul 28.
4
Prominent Lymphatic Vessel Hyperplasia with Progressive Dysfunction and Distinct Immune Cell Infiltration in Lymphedema.
Am J Pathol. 2016 Aug;186(8):2193-2203. doi: 10.1016/j.ajpath.2016.04.006. Epub 2016 Jun 15.
5
Topical tissue nanotransfection of is effective in the prophylactic management of lymphedema.
Mol Ther Nucleic Acids. 2024 Jan 18;35(1):102121. doi: 10.1016/j.omtn.2024.102121. eCollection 2024 Mar 12.
6
A modified mouse-tail lymphedema model.
Lymphology. 2020;53(1):29-37.
10
Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models.
Ann Vasc Surg. 2017 Aug;43:288-295. doi: 10.1016/j.avsg.2017.01.023. Epub 2017 May 4.

引用本文的文献

1
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.
Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.
2
[Research progress on rodent models of secondary lymphedema].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jul 15;39(7):919-924. doi: 10.7507/1002-1892.202504094.
3
Surgical Prevention of Breast Cancer-Related Lymphedema: A Scoping Review.
Lymphatics. 2025 Sep;3(3). doi: 10.3390/lymphatics3030015. Epub 2025 Jun 20.
4
Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics.
Front Bioeng Biotechnol. 2025 Jun 18;13:1558735. doi: 10.3389/fbioe.2025.1558735. eCollection 2025.
5
Mesenchymal stem cell therapy for breast cancer-related secondary lymphedema (Review).
Mol Clin Oncol. 2025 Jun 23;23(2):73. doi: 10.3892/mco.2025.2868. eCollection 2025 Aug.
6
Clinical Relevance of Animal Models of Lymphatic Dysfunction and Lymphedema.
Microcirculation. 2025 May;32(4):e70009. doi: 10.1111/micc.70009.
7
Tissue-Engineered Therapeutics for Lymphatic Regeneration: Solutions for Myocardial Infarction and Secondary Lymphedema.
Adv Healthc Mater. 2025 Mar;14(6):e2403551. doi: 10.1002/adhm.202403551. Epub 2025 Jan 13.
8
Role of inducible nitric oxide (iNOS) and nitrosative stress in regulating sex differences in secondary lymphedema.
Front Physiol. 2024 Dec 3;15:1510389. doi: 10.3389/fphys.2024.1510389. eCollection 2024.
10
Quantification of Lymphangiogenesis in the Murine Lymphedema Tail Model Using Intravital Microscopy.
Lymphat Res Biol. 2024 Jun;22(3):195-202. doi: 10.1089/lrb.2023.0048. Epub 2024 May 3.

本文引用的文献

1
Nanochannel-Based Poration Drives Benign and Effective Nonviral Gene Delivery to Peripheral Nerve Tissue.
Adv Biosyst. 2020 Nov;4(11):e2000157. doi: 10.1002/adbi.202000157. Epub 2020 Sep 16.
2
Exosome-Mediated Crosstalk between Keratinocytes and Macrophages in Cutaneous Wound Healing.
ACS Nano. 2020 Oct 27;14(10):12732-12748. doi: 10.1021/acsnano.0c03064. Epub 2020 Sep 25.
3
Immediate Lymphatic Reconstruction after Axillary Lymphadenectomy: A Single-Institution Early Experience.
Ann Surg Oncol. 2021 Mar;28(3):1381-1387. doi: 10.1245/s10434-020-09104-2. Epub 2020 Sep 9.
4
ASO Author Reflections: Immediate Lymphatic Reconstruction: A Proactive Approach to Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2021 Mar;28(3):1388-1389. doi: 10.1245/s10434-020-09110-4. Epub 2020 Sep 4.
5
A modified mouse-tail lymphedema model.
Lymphology. 2020;53(1):29-37.
6
Deep Inferior Epigastric Artery Vascularized Lymph Node Transfer: A Simple and Safe Option for Lymphedema.
J Plast Reconstr Aesthet Surg. 2020 Oct;73(10):1897-1916. doi: 10.1016/j.bjps.2020.03.017. Epub 2020 May 14.
7
Neurogenic tissue nanotransfection in the management of cutaneous diabetic polyneuropathy.
Nanomedicine. 2020 Aug;28:102220. doi: 10.1016/j.nano.2020.102220. Epub 2020 May 16.
9
Fibrosis and secondary lymphedema: chicken or egg?
Transl Res. 2019 Jul;209:68-76. doi: 10.1016/j.trsl.2019.04.001. Epub 2019 Apr 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验